Drug Shortage Report for TARO-VENLAFAXINE XR
Report ID | 178205 |
Drug Identification Number | 02380099 |
Brand name | TARO-VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-08 |
Estimated end date | 2024-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-12 | English | Compare |
v2 | 2022-12-12 | French | Compare |
v3 | 2023-01-10 | English | Compare |
v4 | 2023-01-10 | French | Compare |
v5 | 2023-01-20 | English | Compare |
v6 | 2023-01-20 | French | Compare |
v7 | 2023-02-01 | English | Compare |
v8 | 2023-02-01 | French | Compare |
v9 | 2023-02-28 | English | Compare |
v10 | 2023-02-28 | French | Compare |
v11 | 2023-03-10 | English | Compare |
v12 | 2023-03-10 | French | Compare |
v13 | 2023-03-24 | English | Compare |
v14 | 2023-03-24 | French | Compare |
v15 | 2023-04-10 | English | Compare |
v16 | 2023-04-10 | French | Compare |
v17 | 2023-05-08 | English | Compare |
v18 | 2023-05-08 | French | Compare |
v19 | 2023-06-09 | English | Compare |
v20 | 2023-06-09 | French | Compare |